Axsome Therapeutics Inc annual earnings per share (EPS) for fiscal TTM was $-3.75, a decrease of 1.9% from $-3.68 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-3.75 | $-3.68 | $-5.99 | $-5.27 | $-4.60 | $-3.59 | $-2.77 | $-2.01 | $-1.15 | $-1.27 | $-1.42 | $-1.02 | $-0.47 | $-0.28 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-0.99 | $-1.26 | $-0.56 | $-0.94 | $-0.97 | $-1.22 | $-1.54 | $-1.34 | $-1.67 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More AXSM metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All AXSM financial statements → Interactive AXSM charts →
About TickerBase · Data methodology & sources · Privacy · Terms